Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesvi...(o $18m in 2008....),Health
Navigation Links
Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
Date:3/13/2008
o $18m in 2008.
'/>"/>
| SOURCE Hillenbrand Industries, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Hillenbrand Industries Announces Fourth Quarter 2007 Dividend
2. Hillenbrand Industries Announces Second Quarter 2008 Dividend
3. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
4. Hillenbrand Industries, Inc. Announces Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
5. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
8. Verdict One Releases Directory of Board Certified Attorneys for Consumers
9. Academy releases emergency preparedness tools to enable millions more people to shelter in place
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. MITEM Releases Blue Iris eLaborate 8.6
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 2Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 3Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 4Health News:Ophthonix Launches iZon(R) SL(TM) Polarized Lenses 2Health News:Ophthonix Launches iZon(R) SL(TM) Polarized Lenses 3Health News:New study finds low rate of injuries at overnight summer camp 2
[0] Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009[0] Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab[0] Shoppers Cautioned Against Poisoning With Holiday Gifts[0] Ophthonix Launches iZon(R) SL(TM) Polarized Lenses[1] New study finds low rate of injuries at overnight summer camp
Other Medicine News:Health News:Prenatal Alcohol Exposure Sets Cognitive Problems After 10 Years 2Health News:Prenatal Alcohol Exposure Sets Cognitive Problems After 10 Years 3
Breaking Medicine Technology:Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Spectrum Surgical Instruments Receives 2009 World Class Customer Service Award 51297 1Spectrum Surgical Instruments Receives 2009 World Class Customer Service Award 51297 2Study Suggests Preseason Shoulder Strength May Determine Injury Severity for Baseball Pitchers 51294 1Study Suggests Preseason Shoulder Strength May Determine Injury Severity for Baseball Pitchers 51294 2Dr Julian Whitaker Featured on Searchhearthealth com 51293 1Dr Julian Whitaker Featured on Searchhearthealth com 51293 2
[0] Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation[0] Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels[0] Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop 2Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop 3
IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |